A detailed history of Harbor Investment Advisory, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Harbor Investment Advisory, LLC holds 22,331 shares of ABBV stock, worth $3.91 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
22,331
Previous 22,878 2.39%
Holding current value
$3.91 Million
Previous $3.92 Million 12.36%
% of portfolio
0.37%
Previous 0.34%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

SELL
$163.84 - $199.33 $89,620 - $109,033
-547 Reduced 2.39%
22,331 $4.41 Million
Q2 2024

Jul 19, 2024

BUY
$154.79 - $180.76 $324,285 - $378,692
2,095 Added 10.08%
22,878 $3.92 Million
Q1 2024

Apr 12, 2024

BUY
$159.82 - $182.1 $22,534 - $25,676
141 Added 0.68%
20,783 $3.78 Million
Q4 2023

Jan 26, 2024

SELL
$137.6 - $154.97 $64,534 - $72,680
-469 Reduced 2.22%
20,642 $3.2 Million
Q3 2023

Oct 13, 2023

SELL
$133.59 - $154.65 $228,839 - $264,915
-1,713 Reduced 7.51%
21,111 $3.15 Million
Q2 2023

Jul 14, 2023

SELL
$132.51 - $164.9 $85,866 - $106,855
-648 Reduced 2.76%
22,824 $3.08 Million
Q1 2023

Apr 21, 2023

BUY
$144.61 - $166.54 $433 - $499
3 Added 0.01%
23,472 $3.74 Million
Q4 2022

Jan 24, 2023

BUY
$138.31 - $165.87 $169,429 - $203,190
1,225 Added 5.51%
23,469 $0
Q3 2022

Nov 01, 2022

SELL
$134.21 - $153.93 $48,852 - $56,030
-364 Reduced 1.61%
22,244 $2.99 Million
Q2 2022

Jul 18, 2022

SELL
$137.62 - $174.96 $161,703 - $205,578
-1,175 Reduced 4.94%
22,608 $3.46 Million
Q1 2022

Apr 20, 2022

SELL
$131.98 - $163.75 $22,568 - $28,001
-171 Reduced 0.71%
23,783 $3.86 Million
Q4 2021

Jan 10, 2022

SELL
$107.43 - $135.93 $26,427 - $33,438
-246 Reduced 1.02%
23,954 $3.24 Million
Q3 2021

Oct 12, 2021

SELL
$106.4 - $120.78 $180,135 - $204,480
-1,693 Reduced 6.54%
24,200 $2.61 Million
Q2 2021

Jul 27, 2021

BUY
$105.21 - $117.21 $79,959 - $89,079
760 Added 3.02%
25,893 $2.92 Million
Q1 2021

Apr 16, 2021

SELL
$102.3 - $112.62 $22,812 - $25,114
-223 Reduced 0.88%
25,133 $2.72 Million
Q4 2020

Feb 04, 2021

BUY
$80.49 - $108.67 $7,727 - $10,432
96 Added 0.38%
25,356 $2.72 Million
Q3 2020

Oct 23, 2020

BUY
$85.91 - $100.83 $15,206 - $17,846
177 Added 0.71%
25,260 $2.21 Million
Q2 2020

Jul 16, 2020

BUY
$73.37 - $98.18 $32,649 - $43,690
445 Added 1.81%
25,083 $2.46 Million
Q1 2020

May 11, 2020

SELL
$64.5 - $97.79 $35,604 - $53,980
-552 Reduced 2.19%
24,638 $1.88 Million
Q4 2019

Jan 16, 2020

BUY
$72.13 - $90.25 $1.82 Million - $2.27 Million
25,190 New
25,190 $2.23 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Harbor Investment Advisory, LLC Portfolio

Follow Harbor Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harbor Investment Advisory, LLC with notifications on news.